13. Hong CW, Kim TK, Ham HY, Nam JS, Kim YH, Zheng H, Pang B, Min TK, Jung JS, Lee SN, Cho HJ, Kim EJ, Hong IH, Kang TC, Lee J, Oh SB, Jung SJ, Kim SJ, Song DK. 2010; Lysophosphatidylcholine increases neutrophil bactericidal activity by enhancement of azurophil granule-phagosome fusion via glycine.GlyR alpha 2/TRPM2/p38 MAPK signaling. J Immunol. 184:4401–4413. DOI:
10.4049/jimmunol.0902814. PMID:
20237295. PMID:
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77952751229&origin=inward.
Article
14. Yan JJ, Jung JS, Lee JE, Lee J, Huh SO, Kim HS, Jung KC, Cho JY, Nam JS, Suh HW, Kim YH, Song DK. 2004; Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat Med. 10:161–167. DOI:
10.1038/nm989. PMID:
14716308. PMID:
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=11144354207&origin=inward.
Article
24. Hara Y, Wakamori M, Ishii M, Maeno E, Nishida M, Yoshida T, Yamada H, Shimizu S, Mori E, Kudoh J, Shimizu N, Kurose H, Okada Y, Imoto K, Mori Y. 2002; LTRPC2 Ca
2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol Cell. 9:163–173. DOI:
10.1016/S1097-2765(01)00438-5. PMID:
11804595. PMID:
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=18244391511&origin=inward.
Article